WO2015062167A8 - Metrnl蛋白在制备降血脂降血糖药物中的应用 - Google Patents
Metrnl蛋白在制备降血脂降血糖药物中的应用 Download PDFInfo
- Publication number
- WO2015062167A8 WO2015062167A8 PCT/CN2014/000949 CN2014000949W WO2015062167A8 WO 2015062167 A8 WO2015062167 A8 WO 2015062167A8 CN 2014000949 W CN2014000949 W CN 2014000949W WO 2015062167 A8 WO2015062167 A8 WO 2015062167A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- application
- hypoglycemic medicine
- preparing
- metrnl
- hypolipidemic
- Prior art date
Links
- 101150115803 metrnl gene Proteins 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 230000000055 hyoplipidemic effect Effects 0.000 title abstract 2
- 230000002218 hypoglycaemic effect Effects 0.000 title abstract 2
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明提供了Metrnl蛋白在制备降血脂、降血糖药物或保健食品中的应用。本发明还提供了Metrnl脂肪特异性过表达小鼠的制备方法。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/137,606 US20160251405A1 (en) | 2013-10-29 | 2016-04-25 | Application of metrnl protein in preparing hypolipidemic, hypoglycemic medicine |
US15/729,420 US10342852B2 (en) | 2013-10-29 | 2017-10-10 | Methods of reducing blood glucose or triglyceride levels by administration of METRNL protein |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310525184.9A CN103536904B (zh) | 2013-10-29 | 2013-10-29 | Metrnl蛋白在制备降血糖药物方面的应用 |
CN201310525184.9 | 2013-10-29 | ||
CN201310525181.5A CN103536903B (zh) | 2013-10-29 | 2013-10-29 | Metrnl蛋白在制备降血脂药物方面的应用 |
CN201310525181.5 | 2013-10-29 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/137,606 Continuation US20160251405A1 (en) | 2013-10-29 | 2016-04-25 | Application of metrnl protein in preparing hypolipidemic, hypoglycemic medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2015062167A1 WO2015062167A1 (zh) | 2015-05-07 |
WO2015062167A8 true WO2015062167A8 (zh) | 2015-12-30 |
Family
ID=53003220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2014/000949 WO2015062167A1 (zh) | 2013-10-29 | 2014-10-27 | Metrnl蛋白在制备降血脂降血糖药物中的应用 |
Country Status (2)
Country | Link |
---|---|
US (2) | US20160251405A1 (zh) |
WO (1) | WO2015062167A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016204700A1 (de) | 2016-03-22 | 2017-09-28 | Universität Rostock | Rekombinante Herstellung von Subfatin |
CN109420158A (zh) * | 2017-09-01 | 2019-03-05 | 上海风劲生物医药科技有限公司 | Metrnl抗血栓用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0639225B1 (en) * | 1992-04-30 | 2002-10-16 | N.V. Innogenetics S.A. | New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
WO2010009732A1 (en) * | 2008-07-24 | 2010-01-28 | Nsgene A/S | Therapeutic use of a growth factor, metrnl |
WO2014116556A2 (en) * | 2013-01-25 | 2014-07-31 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for regulating thermogenesis and muscle inflammation using metrnl and metrn |
CN103536904B (zh) * | 2013-10-29 | 2015-02-18 | 中国人民解放军第二军医大学 | Metrnl蛋白在制备降血糖药物方面的应用 |
CN103536903B (zh) * | 2013-10-29 | 2015-04-15 | 中国人民解放军第二军医大学 | Metrnl蛋白在制备降血脂药物方面的应用 |
-
2014
- 2014-10-27 WO PCT/CN2014/000949 patent/WO2015062167A1/zh active Application Filing
-
2016
- 2016-04-25 US US15/137,606 patent/US20160251405A1/en not_active Abandoned
-
2017
- 2017-10-10 US US15/729,420 patent/US10342852B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20160251405A1 (en) | 2016-09-01 |
WO2015062167A1 (zh) | 2015-05-07 |
US20180030102A1 (en) | 2018-02-01 |
US10342852B2 (en) | 2019-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3359112A4 (en) | SMART MEDICATION CONTAINERS | |
EP3311683A4 (en) | METHOD FOR MANUFACTURING ATOMIZATION UNIT AND ATOMIZATION UNIT | |
WO2015002790A3 (en) | Generating and optimizing protocols | |
EP3398939A4 (en) | ACRYLANILIDE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL APPLICATIONS THEREOF | |
EP3089998A4 (en) | Sulfite-based processes for producing nanocellulose, and compositions and products produced therefrom | |
EP3143246A4 (en) | Real-time, limited orientation sensor auto-calibration | |
EP3055318A4 (en) | Dihydroxyalkyl substituted polygalactomannan, and methods for producing and using the same | |
EP2970068A4 (en) | PROCESS AND SYSTEMS FOR OBTAINING 1,4-BUTANEDIOL FROM FERMENTATION BROTHS | |
EP3039477A4 (en) | Digital microscopy systems, methods and computer program products | |
EP3233157A4 (en) | Infusion system with concurrent tpn/insulin infusion | |
EP3058961A4 (en) | Automatically rotating, high-pressure sterilizer and processing method having continuous operation stages | |
WO2014207571A3 (en) | Lipid extraction processes | |
EP3091003A4 (en) | 1,2-naphthoquinone derivative and method for preparing same | |
EP3020695A4 (en) | Method for producing 2,3,3,3-tetrafluoropropene | |
EP3053008A4 (en) | Selection attractive interfaces, systems and apparatuses including such interfaces, methods for making and using same | |
EP3037407A4 (en) | Method for producing 1,5-pentadiamine | |
HK1222851A1 (zh) | 新的 氰基-二甲基-甲基 -異噁唑及 氰基-二甲基-甲基 噻二唑 | |
EP3013145A4 (en) | Tetrahydrofuran-2,5-dicarbaldehydes (diformyl-tetrahydrofuran, dfthf) and process for making the same | |
EP2796509B8 (en) | Silicone composite particle and a method for preparing the same | |
EP3103815A4 (en) | Hyaluronic acid and/or salt thereof, method for producing same, and food, cosmetic, and pharmaceutical containing said hyaluronic acid and/or salt thereof | |
EP3083145A4 (en) | Abrasive, abrasive article and the method for preparing the same | |
EP3085797A4 (en) | Alloy for medical use, and method for producing same | |
EP3016886A4 (en) | Medicine container, method of assembling the container, and method of dispensing the medicine from the container | |
EP3091005A4 (en) | 1,2-naphthoquinone derivative and method for preparing same | |
EP3045436A4 (en) | Method for producing 1,3-butadiene and/or 3-buten-2-ol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14857086 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14857086 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14857086 Country of ref document: EP Kind code of ref document: A1 |